Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

China flag China · Delayed Price · Currency is CNY
8.00
-0.11 (-1.36%)
Dec 5, 2025, 3:04 PM CST
-6.98%
Market Cap6.73B
Revenue (ttm)1.45B
Net Income (ttm)224.79M
Shares Out829.67M
EPS (ttm)0.27
PE Ratio29.56
Forward PEn/a
Dividend0.08 (0.96%)
Ex-Dividend DateJun 6, 2025
Volume20,800,000
Average Volume22,427,418
Open8.16
Previous Close8.11
Day's Range7.89 - 8.16
52-Week Range6.35 - 8.73
Beta0.11
RSI52.43
Earnings DateApr 15, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China. [Read more]

Sector Healthcare
Founded 1957
Employees 1,490
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002349
Full Company Profile

Financial Performance

In 2024, SHE:002349's revenue was 1.40 billion, a decrease of -7.25% compared to the previous year's 1.51 billion. Earnings were 212.65 million, a decrease of -14.15%.

Financial Statements

News

There is no news available yet.